
Kosher Pie Feminised by DNA Genetics
Kosher Pie Feminised by DNA Genetics results from an elite combination of two of the most valued parents from the seed bank based in Amsterdam. A cross that combines the excellence of Kosher Kush with Cherry 18, which became popular over a decade ago.
Fast shipping 24/72h
Free gift with every order
Discreet packaging
100% secure payment
Description
Now available at Growlobby, Kosher Pie by DNA Genetics is a new addition to the catalogue of Indica varieties with OG genetics, born from the cross Kosher Kush × Cherry 18. A 70/30 hybrid with good resin presence and a fruity profile with that perfect Diesel and sour touch for lovers of potent flavours.
Characteristics of Kosher Pie Feminised by DNA Genetics
Kosher Pie displays an Indica-dominant structure, with dense buds and important trichome coverage during the final weeks of flowering, ideal for users who value the frosty appearance. Indoors, it completes flowering in 9 weeks and the bank places production around 400 g/m².
Aroma Profile of Kosher Pie Feminised
The terpene profile blends sweet fruit with Diesel notes, an earthy nuance and a tart/sour point that gives it character whilst retaining the sweet side of Cherry 18.
Technical Specifications of Kosher Pie Feminised by DNA Genetics
- Seed bank: DNA Genetics
- Genetics: Kosher Kush × Cherry 18
- Seed type: Feminised
- Genotype: 70% Indica / 30% Sativa
- Indoor production: 400 g/m²
- Indoor flowering cycle: 9 weeks
- Flavour profile: fruity, Diesel, earthy and sour
More Information
| Brand | DNA Genetics |
|---|---|
| Gender | Feminised |
| Photoperiod | Photoperiodic |
| Genetics | Chem Dawg, Cookies, Kush, Skunk, Tangie |
| Indica - Sativa | Indica +70% |
| Flavour | Fruity, Citrusy, Sour, Earthy |
| Outdoor flowering | Standard (Early autumn) |
| Indoor Flowering | Medium (8 - 10 weeks) |
| Outdoor Production | High (500 - 800gr/plant) |
| Indoor Production | Medium (350 - 450gr/m2) |
Reviews
The content of this product is for informational and educational use only, never for medical or therapeutic purposes. We remind our customers that cannabis seeds are not listed in the common catalogue of varieties authorised for cultivation in the European Union. They are products intended for genetic preservation, storage and collecting, never for cultivation. We advise customers to review the laws in force in their country, and in no case do we wish to encourage breaking them. All products in the catalogue, including CBD products, contain less than 0.2% THC. CBD products come entirely from industrial hemp varieties.










